Build status - In Progress
An induction and maintenance study to evaluate the efficacy and safety of cc-93538 in adult and adolescent subjects with eosinophilic esophagitis.
Recruiting
12 years - 75 years
All
Phase
3
400 participants needed
1 Location
Brief description of study
Eosinophilic Esophagitis is a chronic, allergic, inflammatory disorder of the esophagus . The allergic substance, which is called an, ‘allergen’, is often not known, and there may be more than one allergen causing your condition. For people with Eosinophilic Esophagitis, the allergen is usually something in the diet, or something that has been inhaled, which causes chronic, or repeating, episodes of inflammation (tissue swelling) in the esophagus. This inflammation usually results in difficulty swallowing, referred to as ‘dysphagia’ (dis-fay-juh). Other symptoms of Eosinophilic Esophagitis may include a feeling that food is stuck between the throat and stomach, chest pain, or upper abdominal pain.
The purpose of this study is to see if CC-93538 is safe and effective as a possible treatment for Eosinophilic Esophagitis.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: eosinophilic esophagitis
-
Age: 12 years - 75 years
-
Gender: All
Male or Female Age 12-75, Diagnosed with Eosinophilic Esophagitis
Updated on
04 Aug 2024.
Study ID: 849018
Find a site
,
Your Information has been sent successfully.
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or